©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Alanine-scanning Mutagenesis of the Subunit of the F-F ATP Synthase from Escherichia coli Reveals Two Classes of Mutants (*)

(Received for publication, May 18, 1995; and in revised form, July 5, 1995)

Hai Xiong Steven B. Vik (§)

From the Department of Biological Sciences, Southern Methodist University, Dallas, Texas 75275

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Alanine-scanning mutagenesis was applied to the subunit of the F(1)-F(0) ATP synthase from E. coli. Nineteen amino acid residues were changed to alanine, either singly or in pairs, between residues 10 and 93. All mutants, when expressed in the deletion strain XH1, were able to grow on succinate minimal medium. Membranes were prepared from all mutants and assayed for ATP-driven proton translocation, ATP hydrolysis ± lauryldiethylamine oxide, and sensitivity of ATPase activity to N,N`-dicyclohexylcarbodiimide (DCCD). Most of the mutants fell into 2 distinct classes. The first group had inhibited ATPase activity, with near normal levels of membrane-bound F(1), but decreased sensitivity to DCCD. The second group had stimulated ATPase activity, with a reduced level of membrane-bound F(1), but normal sensitivity to DCCD. Membranes from all mutants were further characterized by immunoblotting using 2 monoclonal antibodies. A model for the secondary structure of and its role in the function of the ATP synthase has been developed. Some residues are important for the binding of to F(1) and therefore for inhibition. Other residues, from Glu-59 through Glu-70, are important for the release of inhibition by that is part of the normal enzyme cycle.


INTRODUCTION

The F(1)-F(0) ATP synthase from Escherichia coli (for reviews, see (1, 2, 3) ) is composed of eight different types of polypeptide subunits which are coded by eight genes found in a single operon called unc (or atp). The enzyme can be physically separated into a membrane-bound portion called F(0) and a water-soluble portion called F(1). F(1) consists of five types of subunits: alpha (uncA), beta (uncD), (uncG), (uncH), and (uncC) in a stoichiometry of 3:3:1:1:1. F(0) consists of three types of subunits: a (uncB), b (uncF), and c (uncE) in a stoichiometry of 1:2:10 ± 1 (4) .

In the intact F(1)-F(0) complex, the net synthesis of ATP at sites in F(1) is in response to an electrochemical proton gradient across the membrane, which drives proton movement through F(0). This proton movement is coupled to net synthesis of ATP at sites in F(1), probably via a series of conformational changes. Isolated F(1) catalyzes the hydrolysis of ATP, but not its synthesis. The molecular events linking the movement of protons through the membrane-bound portion of the ATPase to the synthesis of ATP at distant sites, remain essentially unknown. Recently, x-ray crystallographic studies of F(1) from bovine mitochondria (5) has provided structural information about alpha, beta, and parts of . In the resulting model, the amino and carboxyl termini of penetrate the central cavity of the alpha(3)beta(3) hexamer, in an asymmetric fashion. One interpretation is that the subunit rotates with respect to alpha and beta, thereby sequentially interacting with different catalytic sites, as indicated by earlier studies(6) .

With the E. coli enzyme, two additional subunits, and , are necessary for the proper binding of the alpha(3)beta(3) complex to F(0). In addition, has the interesting property of acting as an intrinsic inhibitor of ATP hydrolysis by the soluble F(1)(7, 8) . The mechanism by which acts upon the remaining F(1) subunits to cause inhibition is unknown. The removal (or displacement) of from the complex results in about a 6-fold increase in ATP hydrolysis activity(9, 10) . This effect is not dependent upon the presence of the subunit. The subunit is thought to inhibit by reducing the rate of product release(10) , the rate-limiting step in hydrolysis. It is known to bind to isolated subunit(11) , but can be cross-linked to alpha, beta, and subunits(12, 13, 14, 15) .

A series of deletion mutants has been constructed from the carboxyl terminus of and analyzed(16) . A truncated form containing only the first 93 residues, plus 2 serine residues at the new carboxyl terminus, was capable of inhibiting ATP hydrolysis and of promoting the binding of F(1) to F(0). A shorter subunit (80 residues) was also capable of the binding function, but did not have inhibitory properties. These data seem to suggest that an ``inhibitory domain'' exists, composed at least partially of residues between 80 and 93, and that it is distinct from a binding domain in the first 80 residues. Other studies (17, 18) indicated that about 15 amino acids can be lost from the amino terminus without a total loss of function.

Nucleotide-dependent conformational changes in have been detected by protease sensitivity (19) and by cryoelectron microscopy using monoclonal antibodies(20) . An interesting recent result is that second-site suppressors of a c subunit mutation (Q42E) were mapped to -Glu-31. Quite possibly, both and might be intimately involved in the coupling of proton translocation to ATP synthesis, as has been reviewed recently(21) . To probe the interactions of with other subunits, and its role in function, we have applied alanine-scanning mutagenesis(22) .


EXPERIMENTAL PROCEDURES

Materials

Restriction endonucleases and T4 DNA ligase were obtained from New England Biolabs, Inc. Taq DNA polymerase was obtained from Life Technologies, Inc. or from Promega Corp. [alpha-S]dATP was obtained from Amersham. Synthetic oligonucleotides (Fig. 1) were obtained from Operon Technologies, Inc. or from National Biosciences, Inc. Urea was from International Biotechnologies, Inc. ATP was obtained from Boehringer Mannheim. Neutralized phenol-chloroform was obtained from Amresco. Promega Corp. supplied Wizard Minipreps for plasmid isolation for sequencing. ACMA (^1)was obtained from Molecular Probes. LDAO and DCCD were obtained from Fluka. Immunoblotting reagents were obtained from Bio-Rad, and anti- monoclonal antibodies, I and II, were a generous gift of Dr. Roderick Capaldi, University of Oregon(23) .


Figure 1: A, the gene for the subunit, uncC. The darkened regions of the gene indicate segments that have been replaced by synthetic DNA containing additional restriction sites(27) . Sites used in this study have been indicated. B, deoxyoligonucleotides used for cassette mutagenesis. For each pair of oligonucleotides, the two restriction sites used for ligation are indicated at the appropriate ends. The residues that are mutagenized are indicated above the oligonucleotides, and the corresponding new codons are underlined. The following symbols indicate 50% mixtures of bases at a designated position: M = A + C, K = T + G, S = G + C, R = A + G, Y = C + T.



Bacterial Strains

Strain XL1-Blue (recA1, endA1, gyrA96, thi, hsdR17(r(k), m(k)), supE44, relA1, , (lac), (F`, proAB, lacI^q ZDeltaM15, Tn10(Tet^R))) was obtained from Stratagene and was used routinely for subclonings and mutagenesis. Strain XH1 (DeltauncC, bglR, thi-1, rel-1, Hfr PO1) (24) was used to characterize mutations in uncC. It contains a deletion from -2 to 271 in uncC and produces no detectable subunit. It is complemented by plasmid pXH302S, which contains a synthetic version of uncC. Cultures were grown at 37 °C, and cell density was monitored by optical density at 600 nm using a Milton Roy 1001 spectrophotometer. Rich medium was Luria Broth supplemented with 0.2% glucose, and minimal medium was A salts supplemented with succinate (0.2%) or with glucose, as indicated(25) . Media were supplemented with ampicillin (100 mg/liter) or tetracycline (12.5 mg/liter) as appropriate.

Construction of Mutations

Plasmid pXH302S was used to construct the mutations (shown in Fig. 1) using the cassette mutagenesis technique, as described previously(26, 27) . Plasmids were subjected to sequential digestion by each of the two indicated restriction enzymes, followed by ligation with annealed oligonucleotides. Following mutagenesis, plasmids were isolated from transformants (28) and screened by various restriction enzyme digestions to detect the presence of mutations. Subsequently, the DNA sequences of plasmids thought to bear mutations were analyzed using [alpha-S]dATP as described before (26) or by a silver staining technique (Promega) according to the manufacturer's instructions. As indicated in Fig. 1, S10A and F16A were constructed simultaneously in the same plasmid. These mutations were later isolated using a unique SacII restriction site which lies between the two mutations. Most of the other mutations were constructed using degenerate oligonucleotides, which produced mixtures of wild type and mutant residues that were identified after sequence analysis. One mutation, E90A, was never isolated. Mutations were characterized following transformation of the strain XH1.

Preparation of Cell Fractions and Assays

Fractionation of cells and isolation of membranes and stripped membranes were carried out as described(29) . Protein concentrations were determined by the Bio-Rad protein assay using bovine serum albumin as standard. ATP hydrolysis assays were carried out as described (9) with 50 mM Tris acetate, pH 7.5, 3 mM ATP, 5 mM MgCl(2), 5 mM KCN, 2 mM phosphoenolpyruvate, 0.25 mM NADH, pyruvate kinase (6 units), and lactate dehydrogenase (8 units) at 37 °C using a Beckman DU70 spectrophotometer. For release of inhibition by , LDAO was added to the assay medium to a final concentration of 1%(9) . Inhibition of ATP hydrolysis by DCCD was performed as described previously(26) . Fluorescence quenching assays were performed using 400 µg/ml membrane protein in a solution of 50 mM Mops, pH 7.3, 10 mM MgCl(2), 1 µM ACMA, and either 0.5 mM NADH or 0.1 mM ATP, as appropriate. The excitation wavelength was 410 nm and the emission wavelength was 490 nm. Fluorescence quenching was abolished by addition of 1 µM carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone.

Immunoblotting

Samples of membranes (75 µg of protein) were electrophoresed and immunoblotted as described previously(30) , using anti- monoclonal antibodies and goat, anti-mouse IgG-alkaline phosphatase conjugate.


RESULTS

Mutations were constructed as outlined in Fig. 1. Amino acid residues in were converted to alanine to maximize the possibility that the effects of mutagenesis would be confined to local changes. Residues were selected for mutagenesis based on the following criteria. First, partially conserved, and generally polar, residues were selected. Second, the locations of the mutations were generally confined to the first 85 amino acids, the size of that was shown to be sufficient for inhibition of F(1) ATPase activity(16) .

Eighteen mutants, with either single or double alanine substitutions in , were analyzed for growth properties following transformation of the deletion strain XH1. The mutants that were constructed and their growth properties are shown in Table 1. Only 2 mutants, S10A and F16A, grew poorly on minimal succinate medium, as compared to wild type. The measurement of growth yields in minimal glucose medium confirmed those results: S10A (48%), F16A (67%), T77A (85%), and all of the rest were >90% of the wild type level. The results of ATP-driven proton translocation assays by membrane vesicles followed the same pattern: S10A and F16A had no activity, E70A and T77A had 65% and 60% of the wild type activity, respectively, and all of the rest were >90%.



ATP hydrolysis by membrane vesicles from these mutants was measured under three sets of conditions, and the results are shown in Table 1. The standard assay was the coupled enzyme assay at pH 7.5. This assay was repeated in the presence of 1% LDAO, which is known to release the inhibition of F(1) ATPase activity by (9, 31) . The second assay reveals two properties of the mutants. First, it yields the level of uninhibited ATPase activity of the membranes, which reflects the total amount of F(1) bound. Second, when compared with the first assay it shows the fold stimulation upon LDAO addition, which reflects the fold inhibition by . Finally, a third assay was performed after preincubation with DCCD, a specific inhibitor of proton translocation by F(0). Decreased sensitivity of ATPase activity to DCCD reflects ATP hydrolysis that is not obligatorily coupled to proton translocation.

Results of the standard ATP hydrolysis assays revealed that membranes from S10A and F16A had undetectable levels of membrane-bound ATPase. Membranes from the other mutants ranged from 51% to 132% of the wild type levels of ATPase activity, suggesting 2 classes of mutants. This was confirmed by assays in the presence of LDAO, or after preincubation with DCCD. Six mutants showed stimulation of ATP hydrolysis by LDAO of less than 2.4-fold, compared to the wild type value of 3.1-fold. These mutants were T77A, R85A, D81A/R85A, T82A/R85A, T43A, and K46A. This group also tended to have lower levels of bound F(1) ATPase, averaging 61% of wild type, and to have normal sensitivity to DCCD, averaging 60% (95% of the wild type value).

A second class consisted of E70A, S65A, E59A/E60A, K54A/E60A, E59A, and E31A. These mutants showed higher than normal stimulation of ATPase activity by LDAO, with values ranging from 3.5- to 4.6-fold. These mutants showed a more normal level of membrane-bound F(1) ATPase, averaging 85% of the wild type level. However, the membrane-bound ATPase activity was less sensitive to DCCD, averaging only 48% (76% of the wild type level). Six additional mutants, E21A, Q24A, E29A, R51A, K54A, and R93A had properties that were intermediate between the other two classes and were more similar to the wild type.

Membranes from all mutants were subjected to immunoblotting using two previously described monoclonal antibodies to (23) . Both monoclonal antibodies failed to recognize F16A, and S10A was recognized only weakly. The only significant difference between the two antibodies was that I failed to recognize E21A and Q24A.

A sequence alignment and secondary structure prediction was obtained using the EMBL PHD system(32) , and results of the secondary structure predictions are summarized in Fig. 2. Sequences from seven subunits were found to have greater than 30% identity with that of E. coli, and those were used in the secondary structure prediction. Six regions of beta-strand were predicted in the first 78 amino acids, and three regions of alpha-helix were predicted at the carboxyl terminus(79-138), consisting of 5, 16, and 21 residues. Two other regions were weakly predicted to be beta-strands: residues 15-16 and 32-34. Each of the 8 predicted beta-strands shown in Fig. 2has 2 hydrophobic residues separated by a single residue. These residues are underlined. This trend exists in each of the eight sequences and is consistent with amphipathic beta-strands, such as those which would form a beta-barrel or beta-sandwich. The only exception is the second predicted beta-strand, in which the 2 hydrophobic residues are adjacent. Further analysis of 21 bacterial sequences retrieved by BLAST analysis (33) revealed that this pattern of hydrophobic residues was present in each sequence (not shown).


Figure 2: PHD prediction of secondary structure of . The lines labeled AA contain the amino acid sequence of , with the corresponding numbers above. PHD indicates the profile network prediction, where E indicates beta-strand, H indicates alpha-helix, and blank spaces indicate a loop prediction. Rel indicates the reliability index of prediction, on a scale from 0 to 9 (most reliable). SUB indicates a subset of the predictions for which the expected accuracy will be >82%. In this line, loop predictions are indicated by L. Where Rel < 5, no prediction is made, and these are indicated by dots. Underlined residues are the hydrophobic residues in the predicted beta-strands. Other sequences used in the prediction are Vibrio alginolyticus, Bacillus PS3, Bacillus megaterium, Bacillus firmus, Rhodospirillum rubrum, Synechocystis PCC 6803, and Synechococcus PCC 6301.




DISCUSSION

The subunit has a central role in energy transduction by the E. coli F(1)-F(0) ATP synthase. The goal of the present work was to identify by mutagenesis individual amino acids in that are involved in specific roles. Since amino acid replacements can cause a variety of nonlocal effects on protein structure, alanine-scanning mutagenesis (22) was used in this study.

Two mutants, S10A and F16A, seemed to be defective in assembly of the ATP synthase. Residue 10 is predicted to be in the first turn following the first beta-strand. The mutant S10C has previously been characterized (13) and has been cross-linked to via the thiol group. Our results are consistent with the location of residue 10 being near the - interface. In addition, introduction of alanine at position 10 creates a hydrophobic patch at residues 8-11 (VVAA) that may promote misfolding or - aggregation. Others (18) have observed that a deletion of residues 7-14 in caused aggregation.

The mutant F16A is even less functional. Residue 16 resides in the second predicted beta-strand at a position that is always Phe, Tyr, or Trp. Other studies have shown that amino-terminal deletions in of 16 residues are much more severe than are deletions of only 15 residues (17) . Our results also indicate a critical role for residue 16.

Residues Thr-77, Asp-81, Thr-82 and Arg-85 seem to be important for the binding of to other subunits. Each of the four mutants showed reduced levels of membrane-bound F(1) ATPase activity, but this activity was not significantly inhibited by as shown by the low stimulation by LDAO (approximately 1.5 versus 3.1 for wild type). It is not unexpected that mutations that alter binding to other subunits, presumably (11) , would reduce both the binding of F(1) to F(0) in membranes and also the inhibition of ATPase activity by . These residues extend from the eighth predicted beta-strand to the alpha-helical region. This region has been implicated previously in the inhibitory role of by analysis of deletions from the carboxyl terminus(16) . It has also been shown that an -monoclonal antibody has an epitope that is buried in F(1) and part of that epitope is between residues 78 and 85 (18) . Two other mutants analyzed in this study have similar properties: T43A and K46A. These residues lie in a stretch of 15 amino acids between the fourth and fifth predicted beta-strands. It is possible that these residues make up part of the epitope for -mAb-1, described previously(18) .

A second group of mutants has an opposite effect on the inhibitory properties of . This group also contains residues from two distinct regions: residue 31 and residues 59-70. With these mutants a relatively high level of F(1) is bound to membranes, averaging 85% of wild type, but the ATPase activity is highly inhibited. Upon addition of LDAO, the activity is stimulated up to 4.6-fold. It appears that these mutants, E31A, E59A, E60A/K54A, E59A/E60A, S65A, and E70A, form stable F(1)-F(0) complexes, but that the F(1) is locked in an abnormally inhibited state.

Residue Glu-31 is located in the fourth predicted beta-strand and has been mutagenized previously(27) . This residue has also been identified as the site of partial suppressors of the c subunit mutant Q42E(34) . In the present study, E31A was found to reduce the sensitivity of F(1) ATPase to DCCD (76% of wild type). Mutations at the nearby residue His-38 were shown (27) to reduce the sensitivity of F(1) ATPase to DCCD. This evidence tends to support either of the possibilities offered(34) , that this region of interacts directly with the polar loop of c or that it interacts with ``stalk'' subunits, which interact with c. A reduced sensitivity to DCCD by membrane-bound F(1) ATPase is also seen with most of the other members of this group, especially S65A and E70A (70% and 62% of wild type, respectively). Residue 65 is predicted to lie in a loop between the sixth and seventh beta-strands, and residue 70 is part of the predicted seventh beta-strand. The double mutant E59A/E60A also has reduced sensitivity to DCCD, and these residues are found in a loop between the fifth and sixth predicted beta-strands.

The two monoclonal antibodies have been characterized previously with respect to binding of in F(1) and F(1)-F(0), I (5A3-C11), and II (13A7-E9) (23) . Our results reveal a single difference between these two antibodies: I does not recognize the mutants E21A and Q24A. Since it was determined previously (23) that I does not recognize in F(1)-F(0) complexes, but that II does weakly, it is likely that residues 21 and 24 of are shielded by the binding of F(1) to F(0).

The results of the present study contribute to the growing picture of the role of in the structure and function of the F(1)-F(0) ATP synthase. Previous work by others has indicated a two-domain structure for (16) , separated by a ``hinge'' region near residues 80-85(18) . Conformational changes in have been observed via differences in protease sensitivity and in response to ligands at nucleotide binding sites(19) . DCCD has been shown to alter the nucleotide dependence of trypsin cleavage(35) . Movement of relative to other F(1) subunits has been observed via specific cross-linking reagents, also in response to ligands at nucleotide binding sites(6, 12, 13) . The effects of several mutations at the strictly conserved residue His-38 have also been studied. H38C has been shown to be accessible to Ellman's reagent, and the modified remains inhibitory(36) . Two other mutants H38I and H38R were found to have decreased sensitivity to DCCD, but seemed to be highly inhibitory(27) .

A schematic model for the secondary structure of is shown in Fig. 3, based on the PHD secondary structure predictions, hydrophobicity considerations, and the results of our mutagenesis. The model is oriented such that the top would be near the alpha and beta subunits in F(1), and the bottom would be near the c subunits of F(0). The model includes 8 antiparallel beta-strands, 3 alpha-helical segments, and one significant region of undesignated secondary structure. It is proposed that 6 beta-strands are organized into an anti-parallel beta-barrel, and that 2 additional beta-strands form a beta-hairpin. Three of the beta-strands in the barrel are proposed to interact with : primarily strands 2 and 8, and to a small extent strand 1. The other 3 beta-strands in the barrel, 5, 6, and 7, are proposed to form a relatively exposed face that interacts with one or both of the alpha-helical segments. The beta-hairpin, formed by beta-strands 3 and 4, is proposed to be close to F(0) subunits. A region of undesignated secondary structure, found between beta-strands 4 and 5, and the short alpha-helix following beta-strand 8 are both proposed to have interactions with . The sites of alanine mutations are also indicated in Fig. 3.


Figure 3: A secondary structural model of the subunit. The black arrows represent beta-strands, and the white cylinders represent alpha-helices. The sites of alanine mutations are indicated by circles filled with the residue number. Residue 108, the site of cross-linking to beta (12) , is also indicated.



In view of the secondary structure model and the previously described conformational changes of , the following interpretation of these mutations is offered: residues Ser-10, Phe-16, Thr-43, Lys-46, Thr-77, Asp-81, Thr-82, and Arg-85 are proposed to be important for the binding of to other subunits, primarily . Failure to bind properly, due to mutations at these residues, leads to decreased inhibition by , and to some loss of F(1) from membranes. Specifically, the conformation of that stabilizes bound products at the active site is affected, but the functional coupling of F(1) and F(0) is not affected. Residues Glu-31, Lys-54, Glu-59, Glu-60, Ser-65, and Glu-70 are proposed to be important for the release of inhibition that is part of the normal conformational cycle of . Mutations at these residues lead to a highly inhibited form of membrane-bound F(1), and ATPase activity is partially decoupled from proton translocation. These residues might interact with carboxyl-terminal residues of or, in the case of Glu-31, with c subunits(34) . One prediction is that some of these mutants might be resistant to proteolysis by trypsin, independent of nucleotide(19, 35) .


FOOTNOTES

*
This work was supported by United States Public Health Service Grant GM40508 from the National Institutes of Health (to S. B. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence and reprint requests should be addressed. Tel.: 214-768-4228; Fax: 214-768-3955.

(^1)
The abbreviations used are: ACMA, 9-amino,6-chloro,2-methoxyacridine; LDAO, lauryldiethylamine oxide; DCCD, N,N`-dicyclohexylcarbodiimide; Mops, 4-morpholinepropanesulfonic acid.


REFERENCES

  1. Fillingame, R. H. (1990) in The Bacteria (Krulwich, T. A., ed) pp. 345-391, Academic Press, Inc., New York
  2. Futai, M., Noumi, T., and Maeda, M. (1989) Annu. Rev. Biochem. 58,111-136 [CrossRef][Medline] [Order article via Infotrieve]
  3. Senior, A. E. (1990) Annu. Rev. Biophys. Biophys. Chem. 19,7-41 [CrossRef][Medline] [Order article via Infotrieve]
  4. Foster, D. L., and Fillingame, R. H. (1982) J. Biol. Chem. 257,2009-2015 [Abstract/Free Full Text]
  5. Abrahams, J. P., Leslie, A. G. W., Lutter, R., and Walker, J. E. (1994) Nature 370,621-628 [CrossRef][Medline] [Order article via Infotrieve]
  6. Gogol, E. P., Johnston, E., Aggeler, R., and Capaldi, R. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87,9585-9589 [Abstract]
  7. Laget, P. P., and Smith, J. B. (1979) Arch. Biochem. Biophys. 197,83-89 [Medline] [Order article via Infotrieve]
  8. Sternweiss, P. C., and Smith, J. B. (1980) Biochemistry 19,526-531 [Medline] [Order article via Infotrieve]
  9. Lötscher, H. R., deJong, C., and Capaldi, R. A. (1984) Biochemistry 23,4140-4143 [Medline] [Order article via Infotrieve]
  10. Dunn, S. D., Zadorozny, V. D., Tozer, R. G., and Orr, L. E. (1987) Biochemistry 26,4488-4493 [Medline] [Order article via Infotrieve]
  11. Dunn, S. D. (1982) J. Biol. Chem. 257,7354-7359 [Free Full Text]
  12. Dallmann, H. G., Flynn, T. G., and Dunn, S. D. (1992) J. Biol. Chem. 267,18953-18960 [Abstract/Free Full Text]
  13. Aggeler, R., Chicas-Cruz, K., Lai, S. X., Keana, J. F. W., and Capaldi, R. A. (1992) Biochemistry 31,2956-2961 [Medline] [Order article via Infotrieve]
  14. Lötscher, H. R., deJong, C., and Capaldi, R. A. (1984) Biochemistry 23,4134-4140 [Medline] [Order article via Infotrieve]
  15. Stan-Lotter, H., and Bragg, P. D. (1986) Eur. J. Biochem. 154,321-327 [Abstract]
  16. Kuki, M., Noumi, T., Maeda, M., Amemura, A., and Futai, M. (1988) J. Biol. Chem. 263,17437-17442 [Abstract/Free Full Text]
  17. Jounouchi, M., Takeyama, M., Noumi, T., Moriyama, Y., Maeda, M., and Futai, M. (1992) Arch. Biochem. Biophys. 292,87-94 [Medline] [Order article via Infotrieve]
  18. Skakoon, E. N., and Dunn, S. D. (1993) Arch. Biochem. Biophys. 302,279-284 [CrossRef][Medline] [Order article via Infotrieve]
  19. Mendel-Hartvig, J., and Capaldi, R. A. (1991) Biochemistry 30,1278-1284 [Medline] [Order article via Infotrieve]
  20. Wilkens, S., and Capaldi, R. A. (1994) Biol. Chem. Hoppe Seyler 375,43-51 [Medline] [Order article via Infotrieve]
  21. Capaldi, R. A., Aggeler, R., Turina, P., and Wilkens, S. (1994) Trends Biochem. Sci. 19,284-289 [Medline] [Order article via Infotrieve]
  22. Wells, J. A. (1991) Methods Enzymol. 202,390-411 [Medline] [Order article via Infotrieve]
  23. Aggeler, R., Mendel-Hartvig, J., and Capaldi, R. A. (1990) Biochemistry 29,10387-10393 [Medline] [Order article via Infotrieve]
  24. Xiong, H., and Vik, S. B. (1995) J. Bacteriol. 177,851-853 [Abstract]
  25. Miller, J. H. (1972) Experiments in Molecular Genetics , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  26. Vik, S. B., Cain, B. D., Chun, K. T., and Simoni, R. D. (1988) J. Biol. Chem. 263,6599-6605 [Abstract/Free Full Text]
  27. LaRoe, D. L., and Vik, S. B. (1992) J. Bacteriol. 174,633-637 [Abstract]
  28. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  29. Cain, B. D., and Simoni, R. D. (1988) J. Biol. Chem. 263,6606-6612 [Abstract/Free Full Text]
  30. Wang, S., and Vik, S. B. (1994) J. Biol. Chem. 269,3095-3099 [Abstract/Free Full Text]
  31. Dunn, S. D., Tozer, R. G., and Zadorozny, V. D. (1990) Biochemistry 29,4335-4340 [Medline] [Order article via Infotrieve]
  32. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232,584-599 [CrossRef][Medline] [Order article via Infotrieve]
  33. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215,403-410 [CrossRef][Medline] [Order article via Infotrieve]
  34. Zhang, Y., Oldenburg, M., and Fillingame, R. H. (1994) J. Biol. Chem. 269,10221-10224 [Abstract/Free Full Text]
  35. Mendel-Hartvig, J., and Capaldi, R. A. (1991) Biochemistry 30,10987-10991 [Medline] [Order article via Infotrieve]
  36. Skakoon, E. N., and Dunn, S. D. (1993) Arch. Biochem. Biophys. 302,272-278 [CrossRef][Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.